{"id":138741,"date":"2018-04-09T10:14:38","date_gmt":"2018-04-09T10:14:38","guid":{"rendered":"https:\/\/stg.strategist1trial.com\/het-strategist3-onderzoek\/"},"modified":"2025-09-15T16:51:51","modified_gmt":"2025-09-15T16:51:51","slug":"het-strategist3-onderzoek","status":"publish","type":"page","link":"https:\/\/stg.strategist3trial.com\/nl\/","title":{"rendered":"Het StrateGIST3-onderzoek"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112255&#8243; back_repeat=&#8221;no-repeat&#8221; back_attachment=&#8221;scroll&#8221; back_position=&#8221;center center&#8221; parallax=&#8221;yes&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_flip=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_color=&#8221;color-681992&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; el_class=&#8221;gradient&#8221; uncode_shortcode_id=&#8221;821871&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_bottom_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;iphone&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;bottom&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; expand_height=&#8221;yes&#8221; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;7&#8243; align_mobile=&#8221;align_center_mobile&#8221; mobile_width=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;200&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;177675&#8243; column_width_pixel=&#8221;1000&#8243;][vc_empty_space empty_h=&#8221;5&#8243;][vc_single_image media=&#8221;138414&#8243; media_width_percent=&#8221;36&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;624267&#8243;][vc_column_text text_color=&#8221;color-jevc&#8221; uncode_shortcode_id=&#8221;137548&#8243; text_color_type=&#8221;uncode-palette&#8221;]IDRX-42 (GSK6042981) is een zeer selectieve en krachtige remmer van het KIT-eiwit. Dit eiwit is overactief bij veel mensen met GIST, wat leidt tot groei en ophoping van kankercellen.[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112267&#8243; back_repeat=&#8221;no-repeat&#8221; back_attachment=&#8221;fixed&#8221; back_position=&#8221;center top&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_color=&#8221;color-681992&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; row_name=&#8221;iphone&#8221; el_class=&#8221;gradient&#8221; uncode_shortcode_id=&#8221;159258&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_bottom_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;7&#8243; align_mobile=&#8221;align_center_mobile&#8221; mobile_width=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;200&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;276875&#8243; column_width_pixel=&#8221;1000&#8243;][vc_empty_space empty_h=&#8221;1&#8243;][vc_single_image media=&#8221;138414&#8243; media_width_percent=&#8221;45&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;927066&#8243;][vc_empty_space empty_h=&#8221;1&#8243;][vc_button button_color=&#8221;color-681992&#8243; border_width=&#8221;0&#8243; uncode_shortcode_id=&#8221;321186&#8243; width=&#8221;216&#8243; link=&#8221;url:%23study-description|title:FAQs|&#8221; button_color_type=&#8221;uncode-palette&#8221;]Meer informatie[\/vc_button][vc_empty_space empty_h=&#8221;2&#8243;][vc_column_text text_color=&#8221;color-196438&#8243; uncode_shortcode_id=&#8221;111155&#8243; text_color_type=&#8221;uncode-palette&#8221;]Klik hier om een video over StrateGIST 3 te bekijken. De video gaat onder andere over het doel van het onderzoek, wie mee kunnen doen, de onderzoeksmiddelen en wat u kunt verwachten tijdens het onderzoek.[\/vc_column_text][vc_single_image media=&#8221;123013&#8243; media_width_percent=&#8221;100&#8243; uncode_shortcode_id=&#8221;157773&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112266&#8243; back_attachment=&#8221;scroll&#8221; back_position=&#8221;center bottom&#8221; parallax=&#8221;yes&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_color=&#8221;color-681992&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; row_name=&#8221;iphone&#8221; el_class=&#8221;gradient&#8221; uncode_shortcode_id=&#8221;204395&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_bottom_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;7&#8243; align_mobile=&#8221;align_center_mobile&#8221; mobile_width=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;200&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;276875&#8243; column_width_pixel=&#8221;1000&#8243;][vc_empty_space empty_h=&#8221;1&#8243;][vc_single_image media=&#8221;138414&#8243; media_width_percent=&#8221;60&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;482822&#8243;][vc_button button_color=&#8221;color-681992&#8243; border_width=&#8221;0&#8243; uncode_shortcode_id=&#8221;155178&#8243; width=&#8221;216&#8243; link=&#8221;url:%23study-description|title:FAQs|&#8221; button_color_type=&#8221;uncode-palette&#8221;]Meer informatie[\/vc_button][vc_empty_space empty_h=&#8221;0&#8243;][vc_column_text text_color=&#8221;color-196438&#8243; uncode_shortcode_id=&#8221;111155&#8243; text_color_type=&#8221;uncode-palette&#8221;]Klik hier om een video over StrateGIST 3 te bekijken. De video gaat onder andere over het doel van het onderzoek, wie mee kunnen doen, de onderzoeksmiddelen en wat u kunt verwachten tijdens het onderzoek.[\/vc_column_text][vc_empty_space empty_h=&#8221;0&#8243;][vc_single_image media=&#8221;123013&#8243; media_width_percent=&#8221;100&#8243; uncode_shortcode_id=&#8221;157773&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;50&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;4&#8243; bottom_padding=&#8221;3&#8243; back_color=&#8221;color-681992&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; bottom_divider=&#8221;tilt&#8221; uncode_shortcode_id=&#8221;168548&#8243; back_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;study-description&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; column_width_pixel=&#8221;1000&#8243; uncode_shortcode_id=&#8221;145453&#8243;][vc_custom_heading text_color=&#8221;color-138503&#8243; heading_semantic=&#8221;h1&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; uncode_shortcode_id=&#8221;671518&#8243; text_color_type=&#8221;uncode-palette&#8221;]<strong>Wat is StrateGIST 3?<\/strong>[\/vc_custom_heading][vc_column_text text_color=&#8221;color-xsdn&#8221; uncode_shortcode_id=&#8221;775611&#8243; text_color_type=&#8221;uncode-palette&#8221;]<span style=\"font-weight: 400;\"><strong style=\"font-size: 20px; color: #ffffff;\">StrateGIST 3<\/strong> is een klinisch onderzoek waarin een experimenteel medicijn (onderzoeksmiddel) met de naam IDRX-42 (GSK6042981) wordt getest bij volwassenen met uitgezaaide en\/of niet-opereerbare gastro-intestinale stromale tumoren (GIST) bij wie de kanker is teruggekomen tijdens de eerstelijnsbehandeling met imatinib of die deze behandeling niet konden verdragen.<\/span> <span style=\"font-weight: 400;\">Onderzoekers willen meer te weten komen over de veiligheid van IDRX-42 (GSK6042981) en de effecten van het middel vergelijken met sunitinib, een behandeling die in sommige landen is goedgekeurd voor het type GIST dat wordt onderzocht.<\/span> <span style=\"font-weight: 400;\">Dit onderzoek bouwt voort op bevindingen over IDRX-42 (GSK6042981) uit een&nbsp; eerder onderzoek met pati\u00ebnten met GIST.<\/span>[\/vc_column_text][vc_column_text text_color=&#8221;color-xsdn&#8221; uncode_shortcode_id=&#8221;246950&#8243; text_color_type=&#8221;uncode-palette&#8221;]Klik hier om een video over StrateGIST 3 te bekijken. De video gaat onder andere over het doel van het onderzoek, wie mee kunnen doen, de onderzoeksmiddelen en wat u kunt verwachten tijdens het onderzoek.[\/vc_column_text][vc_empty_space empty_h=&#8221;3&#8243;][vc_button button_color=&#8221;color-196438&#8243; border_animation=&#8221;btn-ripple-out&#8221; border_width=&#8221;0&#8243; display=&#8221;inline&#8221; link=&#8221;url:%23location|title:Join%20the%20Study|&#8221; button_color_type=&#8221;uncode-palette&#8221; width=&#8221;216&#8243; uncode_shortcode_id=&#8221;132884&#8243;]Zoek een klinische onderzoekslocatie[\/vc_button][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;7&#8243; bottom_padding=&#8221;7&#8243; back_color=&#8221;color-138503&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_top_divider=&#8221;default&#8221; top_divider=&#8221;tilt&#8221; shape_top_h_use_pixel=&#8221;&#8221; shape_top_height=&#8221;100&#8243; shape_top_color=&#8221;color-681992&#8243; shape_top_opacity=&#8221;100&#8243; shape_top_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider=&#8221;tilt&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;150&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; uncode_shortcode_id=&#8221;152579&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_top_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; sticky=&#8221;yes&#8221; width=&#8221;1\/2&#8243; uncode_shortcode_id=&#8221;179542&#8243;][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;right&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;242247&#8243;][vc_custom_heading text_size=&#8221;&#8221; uncode_shortcode_id=&#8221;506177&#8243;]<strong>Wat gebeurt er tijdens het onderzoek?<\/strong>[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_column_text uncode_shortcode_id=&#8221;183718&#8243;]<span style=\"font-weight: 400\">In het onderzoek wordt het onderzoeksmiddel IDRX-42 getest bij volwassenen met uitgezaaide en\/of niet-opereeerbare gastro-intestinale stromale tumoren (GIST) bij wie de kanker is teruggekomen tijdens de eerstelijnsbehandeling met imatinib of die deze behandeling niet konden verdragen. Het doel is de effecten van IDRX-42 te vergelijken met sunitinib.<\/span><\/p>\n<p><span style=\"font-weight: 400\">IDRX-42 is een onderzoeksmiddel en is door geen enkele gezondheidsautoriteit goedgekeurd voor gebruik buiten een klinisch onderzoek.<\/span>[\/vc_column_text][vc_empty_space empty_h=&#8221;4&#8243;][\/vc_column][vc_column column_width_percent=&#8221;95&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; css_animation=&#8221;alpha-anim&#8221; width=&#8221;1\/2&#8243; uncode_shortcode_id=&#8221;900895&#8243;][vc_custom_heading text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;954054&#8243;]Ge\u00efnformeerde toestemming[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;195636&#8243;]<span style=\"font-weight: 400\">V\u00f3\u00f3r u beslist of u wilt deelnemen, neemt het onderzoeksteam de details van het onderzoek met u door. Dit gaat onder andere over mogelijke risico&#8217;s en voordelen en wat u kunt verwachten als u meedoet. Als u besluit om mee te doen, wordt u gevraagd om een toestemmingsformulier te ondertekenen. Dit bevestigt dat u het onderzoek begrijpt en bereid bent mee te doen om te bepalen of u geschikt bent.<\/span>[\/vc_column_text][vc_separator sep_color=&#8221;color-prif&#8221; uncode_shortcode_id=&#8221;169390&#8243; sep_color_type=&#8221;uncode-palette&#8221;][vc_custom_heading text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;178847&#8243;]<span class='tooltipsall tooltip_post_id_112286 classtoolTips112286'>Screening<\/span>[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;350149&#8243;]<span style=\"font-weight: 400\">Om te kijken of u in aanmerking komt, heeft u minstens \u00e9\u00e9n afspraak op de onderzoekslocatie om vragen over uw gezondheid en medicatie te beantwoorden en om een aantal tests te ondergaan.<\/span>[\/vc_column_text][vc_separator sep_color=&#8221;color-prif&#8221; uncode_shortcode_id=&#8221;169390&#8243; sep_color_type=&#8221;uncode-palette&#8221;][vc_custom_heading text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;209503&#8243;]Onderzoeksbehandeling[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;132873&#8243;]<span style=\"font-weight: 400\">Als u in aanmerking komt voor deelname aan het onderzoek, wordt u willekeurig in een groep ingedeeld waarin u ofwel IDRX-42 of sunitinib (de goedgekeurde behandeling) krijgt.&nbsp;<\/span><\/p>\n<p><span style=\"font-weight: 400\">IDRX-42 wordt verstrekt als tabletten die eenmaal per dag thuis worden ingenomen. IDRX-42 wordt elke dag ingenomen. Sunitinib wordt 28 dagen achtereen ingenomen, gevolgd door een pauze van 14 dagen (tenzij u andere instructies krijgt van uw arts).&nbsp;<\/span><\/p>\n<p><span style=\"font-weight: 400\">Tijdens de periode met de onderzoeksbehandeling komt u naar de onderzoekslocatie voor gezondheidscontroles en om te zien hoe uw kanker reageert op de onderzoeksbehandeling (IDRX-42 of sunitinib).<\/span><\/p>\n<p><span style=\"font-weight: 400\">Als u sunitinib krijgt en uw kanker verergert, kunt u mogelijk overschakelen naar IDRX-42.<\/span><\/p>\n<p><strong>De onderzoeksbehandeling (IDRX-42 of sunitinib), afspraken en onderzoeksgerelateerde tests zullen worden betaald door de opdrachtgever van het klinisch onderzoek. Er is een vergoeding beschikbaar voor reiskosten om naar afspraken te komen.<\/strong>[\/vc_column_text][vc_separator sep_color=&#8221;color-prif&#8221; uncode_shortcode_id=&#8221;447472&#8243; sep_color_type=&#8221;uncode-palette&#8221;][vc_custom_heading text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;165143&#8243;]Opvolging[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;435261&#8243;]<span style=\"font-weight: 400\">Als u en uw arts besluiten te stoppen met de onderzoeksbehandeling, heeft u nog twee afspraken en elke drie maanden een telefonisch gesprek met het onderzoeksteam.<\/span>[\/vc_column_text][vc_empty_space empty_h=&#8221;2&#8243;][vc_button button_color=&#8221;color-681992&#8243; border_animation=&#8221;btn-ripple-out&#8221; border_width=&#8221;0&#8243; uncode_shortcode_id=&#8221;626023&#8243; link=&#8221;url:https%3A%2F%2Fstg.strategist1trial.com%2Fnl%2Fveelgestelde-vragen%2F|title:FAQs|&#8221; button_color_type=&#8221;uncode-palette&#8221;]Bekijk de veelgestelde vragen over StrateGIST 3[\/vc_button][vc_empty_space empty_h=&#8221;2&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; back_color=&#8221;color-138503&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_top_divider=&#8221;default&#8221; top_divider=&#8221;tilt&#8221; shape_top_h_use_pixel=&#8221;&#8221; shape_top_height=&#8221;100&#8243; shape_top_color=&#8221;color-681992&#8243; shape_top_opacity=&#8221;100&#8243; shape_top_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider=&#8221;tilt&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;150&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;944839&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_top_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; sticky=&#8221;yes&#8221; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;580905&#8243;][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;right&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;111259&#8243;][vc_empty_space empty_h=&#8221;3&#8243;][vc_custom_heading text_size=&#8221;&#8221; uncode_shortcode_id=&#8221;506177&#8243;]<strong>Wat gebeurt er tijdens het onderzoek?<\/strong>[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;105390&#8243;]<span style=\"font-weight: 400;\">In het onderzoek wordt het onderzoeksmiddel IDRX-42 (GSK6042981) getest bij volwassenen met uitgezaaide en\/of niet-opereerbare gastro-intestinale stromale tumoren (GIST) bij wie de ziekte erger is geworden tijdens de behandeling met imatinib of die de bijwerkingen van imatinib niet verdragen. Het doel is de veiligheid en effecten van IDRX-42 (GSK6042981) te vergelijken met sunitinib.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">IDRX-42 (GSK6042981) is een onderzoeksmiddel en is door geen enkele gezondheidsautoriteit goedgekeurd voor gebruik buiten een klinisch onderzoek.<\/span>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;158094&#8243;][vc_custom_heading uncode_shortcode_id=&#8221;175823&#8243;]Uw traject in StrateGIST 3[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; limit_content=&#8221;&#8221; uncode_shortcode_id=&#8221;663441&#8243;][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;158744&#8243;][vc_single_image media=&#8221;138975&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;173253&#8243;][vc_single_image media=&#8221;139044&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;142390&#8243;][vc_single_image media=&#8221;139021&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;118299&#8243;][vc_single_image media=&#8221;138998&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;100999&#8243;][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; limit_content=&#8221;&#8221; uncode_shortcode_id=&#8221;143909&#8243;][vc_column_inner width=&#8221;1\/1&#8243;][vc_single_image media=&#8221;138534&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;165287&#8243;][vc_single_image media=&#8221;138474&#8243; media_width_percent=&#8221;11&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;197707&#8243;][vc_single_image media=&#8221;138514&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;840834&#8243;][vc_single_image media=&#8221;138474&#8243; media_width_percent=&#8221;11&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;746250&#8243;][vc_single_image media=&#8221;112312&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;108810&#8243;][vc_single_image media=&#8221;138474&#8243; media_width_percent=&#8221;11&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;121070&#8243;][vc_single_image media=&#8221;138494&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;868346&#8243;][\/vc_column_inner][\/vc_row_inner][vc_empty_space empty_h=&#8221;3&#8243;][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;888870&#8243;][vc_button border_width=&#8221;0&#8243; link=&#8221;url:https%3A%2F%2Fstg.strategist1trial.com%2Fnl%2Fveelgestelde-vragen%2F|title:FAQs|&#8221; uncode_shortcode_id=&#8221;185672&#8243;]FAQs[\/vc_button][vc_empty_space empty_h=&#8221;3&#8243;][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; back_color=&#8221;color-xsdn&#8221; back_image=&#8221;111788&#8243; parallax=&#8221;yes&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_top_divider=&#8221;default&#8221; top_divider=&#8221;tilt&#8221; shape_top_h_use_pixel=&#8221;&#8221; shape_top_height=&#8221;100&#8243; shape_top_opacity=&#8221;100&#8243; shape_top_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider=&#8221;tilt&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; uncode_shortcode_id=&#8221;155709&#8243; back_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;locations&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;881793&#8243; column_width_pixel=&#8221;900&#8243;][vc_empty_space][vc_custom_heading text_size=&#8221;&#8221; uncode_shortcode_id=&#8221;176181&#8243;]<span style=\"font-weight: 400\">Wilt u meer weten? <\/span>[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;183639&#8243;]<span style=\"font-weight: 400\">Vraag uw arts om meer informatie en klik op de link hieronder om een StrateGIST 1-onderzoekslocatie bij u in de buurt te vinden.<\/span>[\/vc_column_text][vc_column_text uncode_shortcode_id=&#8221;654154&#8243;]<b>Deelname aan het onderzoek is vrijwillig en u kunt op elk moment met het onderzoek stoppen.<\/b>[\/vc_column_text][vc_empty_space empty_h=&#8221;2&#8243;][vc_button button_color=&#8221;color-773321&#8243; border_animation=&#8221;btn-ripple-out&#8221; border_width=&#8221;0&#8243; uncode_shortcode_id=&#8221;214268&#8243; link=&#8221;url:https%3A%2F%2Fstg.strategisttrials.com%2Ffaqs%2F|title:FAQs|&#8221; button_color_type=&#8221;uncode-palette&#8221;]Zoek een klinische onderzoekslocatie[\/vc_button][vc_empty_space empty_h=&#8221;5&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;936538&#8243; back_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;location&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;881793&#8243; column_width_pixel=&#8221;900&#8243;][vc_custom_heading text_size=&#8221;&#8221; uncode_shortcode_id=&#8221;118699&#8243;]Wilt u meer weten?[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;125329&#8243;]<span style=\"font-weight: 400;\">Vraag uw arts om meer informatie over StrateGIST 3.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Klik op een locatie op de kaart hieronder om een StrateGIST 3-onderzoekslocatie bij u in de buurt te vinden. StrateGIST 3 zal beschikbaar zijn in maximaal 150 locaties voor klinische onderzoeken wereldwijd. Houd de locaties in de gaten, er zullen nieuwe locaties openen.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Reiskosten om naar onderzoeksafspraken te komen worden vergoed.<\/span>[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;2&#8243; bottom_padding=&#8221;5&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;150898&#8243; back_color_type=&#8221;uncode-palette&#8221;][vc_column width=&#8221;1\/1&#8243;][vc_column_text uncode_shortcode_id=&#8221;326645&#8243;]                <script>\r\n                    const mapStyle = [];\r\n                    const marker_icon = '';\r\n                <\/script>\r\n\t\t\t            <div class=\"store-info-container \">\r\n                <div class=\"store-locations\">\r\n                    <div class=\"store-locations-search OneLinkTx\">\r\n                        <form role=\"search\" class=\"store-search-form\">\r\n                            <label for=\"search-text\"><\/label>\r\n                            <input type=\"text\" value name=\"search-text\" id=\"search-text\"\r\n                                   placeholder=\"Enter a location\">\r\n                            <input type=\"image\" id=\"search-btn\" alt=\"Search\" src=\"https:\/\/stg.strategist3trial.com\/wp-content\/plugins\/jh-wp-site-listing-main\/images\/icon-arrow-right.svg\">\r\n                            <input type=\"hidden\" id=\"place_lat\" value=\"\">\r\n                            <input type=\"hidden\" id=\"place_lng\" value=\"\">\r\n                            <input type=\"hidden\" id=\"show_map\" name=\"show_map\"\r\n                                   value=\"yes\">\r\n\t\t\t\t\t\t\t                            <input type=\"hidden\" id=\"language_code\" value=\"nl\">\r\n                        <\/form>\r\n\t\t\t\t\t\t                            <div class=\"my-location\">\r\n                                <a href=\"javascript:void(0);\" onClick=\"getuser_location();\">\r\n\t\t\t\t\t\t\t\t\tUse my Location                                <\/a>\r\n                            <\/div>\r\n\t\t\t\t\t\t                    <\/div>\r\n                    <h5 class=\"store-locations-result-info OneLinkTx\">\r\n\t\t\t\t\t\tShowing                        <span id=\"found-results\"> 0<\/span> Results Near You                    <\/h5>\r\n\t\t\t\t\t                    <div class=\"store-locations-list\" id=\"ajax_results_wrapper\">\r\n                    <\/div>\r\n                <\/div>\r\n\t\t\t\t                    <div class=\"store-map-wrapper\">\r\n                        <div id=\"store-map\">\r\n                        <\/div>\r\n                    <\/div>\r\n\t\t\t\t            <\/div>\r\n\t\t\t[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; uncode_shortcode_id=&#8221;107948&#8243;][vc_column width=&#8221;1\/1&#8243;][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/4&#8243; uncode_shortcode_id=&#8221;136670&#8243;][vc_raw_html]W3Rvb2x0aXBzIGtleXdvcmQgPSAiPGltZyBzcmM9Imh0dHBzOi8vc3RnLnN0cmF0ZWdpc3QxdHJpYWwuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDI0LzExL0lDLnBuZyIvPiIgY29udGVudCA9ICI8aDM+R2XDr25mb3JtZWVyZGUgdG9lc3RlbW1pbmc8L2gzPjxkaXY+PHAgc3R5bGU9ImZvbnQtc2l6ZTo4MHB4ICFpbXBvcnRhbnQiPlbDs8OzciB1IGJlc2xpc3Qgb2YgdSB3aWx0IGRlZWxuZW1lbiwgbmVlbXQgaGV0IG9uZGVyem9la3N0ZWFtIGRlIGRldGFpbHMgdmFuIGhldCBvbmRlcnpvZWsgbWV0IHUgZG9vci4gRGl0IGdhYXQgb25kZXIgYW5kZXJlIG92ZXIgbW9nZWxpamtlIHJpc2ljbydzIGVuIHZvb3JkZWxlbiBlbiB3YXQgdSBrdW50IHZlcndhY2h0ZW4gYWxzIHUgbWVlZG9ldC4gQWxzIHUgYmVzbHVpdCBvbSBtZWUgdGUgZG9lbiwgd29yZHQgdSBnZXZyYWFnZCBvbSBlZW4gdG9lc3RlbW1pbmdzZm9ybXVsaWVyIHRlIG9uZGVydGVrZW5lbi4gRGl0IGJldmVzdGlndCBkYXQgdSBoZXQgb25kZXJ6b2VrIGJlZ3JpanB0IGVuIGJlcmVpZCBiZW50IG1lZSB0ZSBkb2VuIG9tIHRlIGJlcGFsZW4gb2YgdSBnZXNjaGlrdCBiZW50LjwvcD48YnI+PGJyPjwvZGl2PiJd[\/vc_raw_html][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;961362&#8243; subheading=&#8221;(meer informatie over het onderzoek en instemmen met deelname)&#8221;]Ge\u00efnformeerde toestemming[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/4&#8243; uncode_shortcode_id=&#8221;443498&#8243;][vc_raw_html]W3Rvb2x0aXBzIGtleXdvcmQgPSAiPGltZyBzcmM9Imh0dHBzOi8vc3RnLnN0cmF0ZWdpc3QxdHJpYWwuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDI0LzExL2hlYWx0aC1zdGF0dXMucG5nIi8+IiBjb250ZW50ID0gIjxoMz5TY3JlZW5pbmc8L2gzPjxkaXY+PGg2Pk9tIHRlIGtpamtlbiBvZiB1IGluIGFhbm1lcmtpbmcga29tdCwgaGVlZnQgdSBtaW5zdGVucyDDqcOpbiBhZnNwcmFhayBvcCBkZSBvbmRlcnpvZWtzbG9jYXRpZSBvbSB2cmFnZW4gb3ZlciB1dyBnZXpvbmRoZWlkIGVuIG1lZGljYXRpZSB0ZSBiZWFudHdvb3JkZW4gZW4gb20gZWVuIGFhbnRhbCB0ZXN0cyB0ZSBvbmRlcmdhYW4uPC9oNj48YnI+PGJyPjwvZGl2PiJd[\/vc_raw_html][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;927570&#8243; subheading=&#8221;(kijken of u in aanmerking komt)&#8221;]<span class='tooltipsall tooltip_post_id_112286 classtoolTips112286'>Screening<\/span>[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/4&#8243; uncode_shortcode_id=&#8221;755785&#8243;][vc_raw_html]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[\/vc_raw_html][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;665102&#8243; subheading=&#8221;IDRX-42 of sunitinib&#8221;]Onderzoeksbehandeling[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/4&#8243; uncode_shortcode_id=&#8221;127480&#8243;][vc_raw_html]W3Rvb2x0aXBzIGtleXdvcmQgPSAiPGltZyBzcmM9Imh0dHBzOi8vc3RnLnN0cmF0ZWdpc3QxdHJpYWwuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDI0LzExL0FnZS5wbmciLz4iIGNvbnRlbnQgPSAiPGgyPk9wdm9sZ2luZzwvaDI+PGRpdj48aDY+QWxzIHUgZW4gdXcgYXJ0cyBiZXNsdWl0ZW4gdGUgc3RvcHBlbiBtZXQgZGUgb25kZXJ6b2Vrc2JlaGFuZGVsaW5nLCBoZWVmdCB1IG5vZyB0d2VlIGFmc3ByYWtlbiBlbiBlbGtlIGRyaWUgbWFhbmRlbiBlZW4gdGVsZWZvbmlzY2ggZ2VzcHJlayBtZXQgaGV0IG9uZGVyem9la3N0ZWFtLjwvaDY+PGJyPjxicj48L2Rpdj4iXQ==[\/vc_raw_html][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;152286&#8243;]Opvolging[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112255&#8243; back_repeat=&#8221;no-repeat&#8221; back_attachment=&#8221;scroll&#8221; back_position=&#8221;center center&#8221; parallax=&#8221;yes&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_flip=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-138741","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/stg.strategist3trial.com\/nl\/wp-json\/wp\/v2\/pages\/138741","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stg.strategist3trial.com\/nl\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/stg.strategist3trial.com\/nl\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/stg.strategist3trial.com\/nl\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/stg.strategist3trial.com\/nl\/wp-json\/wp\/v2\/comments?post=138741"}],"version-history":[{"count":0,"href":"https:\/\/stg.strategist3trial.com\/nl\/wp-json\/wp\/v2\/pages\/138741\/revisions"}],"wp:attachment":[{"href":"https:\/\/stg.strategist3trial.com\/nl\/wp-json\/wp\/v2\/media?parent=138741"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}